StonvexLoading…
StonvexStonvexStonvexCore line items from HXHX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $33.04M | $25.57M | $26.66M | $28.95M |
Operating Income | $7.79M | $5.54M | $6.01M | $6.21M |
Net Income | $3.97M | $3.17M | $3.97M | $4.29M |
EPS (Diluted) | $0.30 | $0.26 | $0.33 | $0.36 |
Total Assets | $50.27M | $32.38M | $28.15M | Not available |
Total Liabilities | $22.65M | $14.01M | $12.45M | Not available |
Cash & Equivalents | $1.40M | $170.43K | $86.29K | $101.67K |
Free Cash Flow OCF − CapEx | $-14.02M | $-3.96M | $921.34K | $-500.62K |
Shares Outstanding | 13.25M | 12.00M | 12.00M | 12.00M |